These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Review article: targeting the B cell activation system in autoimmune hepatitis. Czaja AJ Aliment Pharmacol Ther; 2021 Oct; 54(7):902-922. PubMed ID: 34506662 [TBL] [Abstract][Full Text] [Related]
3. Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis. Czaja AJ Dig Dis Sci; 2021 Aug; 66(8):2493-2512. PubMed ID: 32833154 [TBL] [Abstract][Full Text] [Related]
4. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Plosker GL; Figgitt DP Drugs; 2003; 63(8):803-43. PubMed ID: 12662126 [TBL] [Abstract][Full Text] [Related]
5. Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis. Czaja AJ Dig Dis Sci; 2022 Apr; 67(4):1163-1186. PubMed ID: 33835375 [TBL] [Abstract][Full Text] [Related]
6. Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin. Ly S; Nedosekin D; Wong HK Am J Clin Dermatol; 2023 Mar; 24(2):247-273. PubMed ID: 36630066 [TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis. Singh S; Murad MH; Fumery M; Sedano R; Jairath V; Panaccione R; Sandborn WJ; Ma C Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):1002-1014. PubMed ID: 34688373 [TBL] [Abstract][Full Text] [Related]
9. A review article on biosimilar infliximab SB2 in the treatment of rheumatoid arthritis. Bellinvia S; Ashraf M; Polosa R; Edwards C Immunotherapy; 2017 Nov; 9(14):1133-1142. PubMed ID: 29067885 [TBL] [Abstract][Full Text] [Related]
10. [Recombinant proteins or monoclonal antibodies: comparative properties and interest in systemic lupus erythematosus]. Terrier B; Mouthon L Med Sci (Paris); 2013 Jan; 29(1):65-73. PubMed ID: 23351696 [TBL] [Abstract][Full Text] [Related]
11. Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis. Czaja AJ Autoimmunity; 2019 Jun; 52(4):144-160. PubMed ID: 31298041 [TBL] [Abstract][Full Text] [Related]
12. Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part II. Czaja AJ Inflamm Allergy Drug Targets; 2012 Oct; 11(5):351-63. PubMed ID: 22563780 [TBL] [Abstract][Full Text] [Related]